T cell specific adaptor protein (TSAd) promotes interaction of Nck with Lck and SLP-76 in T cells by unknown
RESEARCH Open Access
T cell specific adaptor protein (TSAd)
promotes interaction of Nck with Lck and
SLP-76 in T cells
Cecilie Dahl Hem1, Vibeke Sundvold-Gjerstad1, Stine Granum1, Lise Koll1, Greger Abrahamsen1, Laszlo Buday2
and Anne Spurkland1,3*
Abstract
Background: The Lck and Src binding adaptor protein TSAd (T cell specific adaptor) regulates actin polymerization
in T cells and endothelial cells. The molecular details as to how TSAd regulates this process remain to be
elucidated.
Results: To identify novel interaction partners for TSAd, we used a scoring matrix-assisted ligand algorithm (SMALI),
and found that the Src homology 2 (SH2) domain of the actin regulator Non-catalytic region of tyrosine kinase
adaptor protein (Nck) potentially binds to TSAd phosphorylated on Tyr280 (pTyr280) and pTyr305. These predictions
were confirmed by peptide array analysis, showing direct binding of recombinant Nck SH2 to both pTyr280 and
pTyr305 on TSAd. In addition, the SH3 domains of Nck interacted with the proline rich region (PRR) of TSAd.
Pull-down and immunoprecipitation experiments further confirmed the Nck-TSAd interactions through Nck SH2
and SH3 domains. In line with this Nck and TSAd co-localized in Jurkat cells as assessed by confocal microscopy
and imaging flow cytometry. Co-immunoprecipitation experiments in Jurkat TAg cells lacking TSAd revealed that
TSAd promotes interaction of Nck with Lck and SLP-76, but not Vav1. TSAd expressing Jurkat cells contained more
polymerized actin, an effect dependent on TSAd exon 7, which includes interactions sites for both Nck and Lck.
Conclusions: TSAd binds to and co-localizes with Nck. Expression of TSAd increases both Nck-Lck and Nck-SLP-76
interaction in T cells. Recruitment of Lck and SLP-76 to Nck by TSAd could be one mechanism by which TSAd
promotes actin polymerization in activated T cells.
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Background
Regulation of actin dynamics is important for several as-
pects of T cell function, including differentiation, migra-
tion through tissues and proliferation. T cell activation
initiates multiple molecular events including activation
of protein tyrosine kinases, the formation of protein sig-
naling complexes, and cytoskeletal actin reorganization
leading to establishment of the immunological synapse
(IS) at the T cell-antigen presenting cell (APC) interface
[1, 2]. Briefly, following T cell receptor (TCR) ligation the
tyrosine kinases Lck and Zap-70 become activated, leading
to the formation of a signaling complex containing the
adaptor proteins linker for activation of T cells (LAT),
SH2 domain containing leukocyte protein of 76 kDa
(SLP-76) and non-catalytic region of tyrosine kinase
adaptor protein (Nck) [2].
The molecular aspects concerning actin dynamics in T
cells are complex, and many questions remain to be
solved. One of the more recently identified players of
actin reorganization is the T cell specific adaptor protein
(TSAd) [3] encoded by the SH2D2A gene. TSAd inter-
acts with and modulates the activity of the Src family
protein tyrosine kinase Lck [4, 5] as well as Src itself [6].
TSAd has been found to control actin polymerization
events in T cells and endothelial cells. More specifically,
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in response to VEGF-A stimulation, TSAd is required
for stress fiber formation and migration of endothelial
cells [7]. Moreover, we have also shown that TSAd regu-
lates CXCL12-induced migration and actin cytoskeletal
rearrangements in T cells by promoting Lck dependent
tyrosine phosphorylation of IL2-inducible T-cell kinase
(Itk) [8].
To better understand the function of TSAd, we used
an algorithm for identification of SH2 domain-ligand
pairs (SMALI) to identify possible binding partners for
the TSAd phosphotyrosines. SMALI pointed to a pos-
sible interaction between TSAd and the adaptor Nck.
Nck is known to regulate the actin cytoskeleton. It con-
sists of one C-terminal Src homology 2 (SH2) domain
and three N-terminal SH3 domains which allows for
multiple protein-protein interactions. More than 60
interaction partners for Nck have been identified [9, 10].
Nck interacts constitutively with the guanine nucleotide
exchange factor Vav1 [11]. Upon TCR-triggering, Nck and
Vav1 interacts with SLP-76, leading to the activation of
the actin rearrangement at the T-cell APC interface. Thus,
Nck is a key adaptor in T cell activation-dependent actin
filament formation through its interactions with compo-
nents of the TCR/CD3 complex and cytoskeletal regula-
tors including Vav1 and SLP-76 [9, 12–14]. Nck plays a
universal role in regulation of the signaling networks
critical for organizing the actin cytoskeleton; including
formation of the IS following TCR engagement, cell prolif-
eration and cell migration [9, 15, 16].
Here we explored the possible interaction between
TSAd and Nck using intact and mutated TSAd and Nck
constructs. We found that the Nck SH2 domain binds to
both TSAd pTyr280 and TSAd pTyr305, with pTyr280 as
the preferred binding site. Additionally, two of the three
Nck SH3 domains were found to interact with the PRR
on TSAd, presumably in a cooperative manner. Our data
indicate the existence of a direct interaction between of
Nck and TSAd. When TSAd is co-expressed, interaction
of Nck with Lck is increased. Moreover, TSAd also enables
Nck to interact with SLP-76, an interaction previously
shown to be important for actin polymerization and re-
arrangement [17]. TSAd promoted actin polymerization
in Jurkat cells, and this was dependent on TSAd exon 7
encoding interaction sites for both Nck and Lck. Thus,
the Nck-TSAd interaction may represent an additional
link whereby TSAd contributes to the regulation of the
actin cytoskeleton in T cells.
Results
The Nck SH2 domain interacts with TSAd-pTyr280
and -pTyr305
TSAd possesses several protein interaction motifs, in-
cluding an N-terminally located SH2 domain, and a C-
terminal part consisting of a PRR and several tyrosine
phosphorylation sites. TSAd is tyrosine phosphorylated
in non-stimulated Jurkat cells [4, 18] and in peripheral
blood mononuclear cells [3] while increased amount of
tyrosine phosphorylated TSAd may be seen upon TCR
stimulation [18]. To identify novel SH2 domain containing
binding partners for TSAd, we performed an in silico scan
using the SMALI algorithm [19, 20]. A relative SMALI
score >1.0, strongly indicates potential binding between
an SH2 domain and a phosphotyrosine containing ligand.
SMALI identified the Nck SH2 domain as a possible inter-
action partner for TSAd pTyr260, pTyr280 and pTyr305,
(relative SMALI scores: 1.05, 1.37 and 1.10 respectively)
(Fig. 1a). In comparison, the Lck-SH2 domain already
known to bind to the three C-terminal TSAd phosphotyr-
osines [5], displayed a SMALI score of 1.21 for TSAd-
pTyr305. To test the SMALI predictions, we carried out a
peptide array analysis of 15-mer TSAd phosphotyrosine
peptides spotted to a nitrocellulose membrane. Recombin-
ant GST-Nck SH2 protein showed direct binding to both
TSAd pTyr280 and pTyr305 while the TSAd pTyr260 phos-
phopeptide only revealed a weak signal (Fig. 1b). In ac-
cordance with the SMALI predictions, the pTyr280
interaction displayed the strongest signal (Fig. 1b).
Interaction between Nck and TSAd was then assessed
by in vitro pull-down interaction analysis in lysates from
293T cells transiently expressing TSAd as well as the kin-
ase Lck to ensure phosphorylation of TSAd [4, 18]. The
constructs used for transfections are depicted in Fig. 1c
and d. TSAd exists in different phosphorylation forms,
with different migration in SDS-PAGE [5]. In the absence
of Lck, the lower band predominates (Fig. 1e, lane 1). Nck
SH2 protein pulled down TSAd or TSAd lacking its PRR
from 293T cells only when co-expressed with Lck (Fig. 1e,
lane 3 and 6). In contrast TSAd lacking the three penulti-
mate tyrosines known to be phosphorylated by Lck [5],
failed to interact (Fig. 1e, lane 4). Moreover, Nck SH2 did
not interact with Lck in this experiment (data not shown).
We previously showed that removal of the TSAd PRR is
associated with reduced phosphorylation of TSAd [5]. In
line with this observation, the absence of TSAd PRR re-
sults in reduced interaction between the GST-Nck SH2
domain and TSAd (Fig. 1e, lane 6) compared to TSAd
WT.
Further analysis revealed that substantially less of the
TSAd Tyr280→ Phe280 (Y280F) mutant was pulled down
with Nck SH2, while Nck SH2 could still pull down the
TSAd Y305F protein (Fig. 1f ). Elimination of Tyr290 did
not affect TSAd’s binding to Nck SH2 in 293T cells (Fig.
1f ), as predicted by SMALI and shown in the peptide
array analysis (Fig. 1b). GST alone did not bind to TSAd
(data not shown). The results presented in Fig. 1f re-
vealed that single mutations of TSAd Tyr280, Tyr290 and
Tyr305 did not completely abolish binding between
TSAd and the Nck SH2 domain. We thus proceeded to






Fig. 1 TSAd-pTyr280 and -pTyr305 interact with the Nck SH2 domain. a SH2 domain interaction partners to TSAd phosphotyrosines predicted by SMALI. The
five best candidates are listed. Scores > 1 indicate a potential interaction.”-“indicates a SMALI score < 1. b Peptide spot array spotted with indicated TSAd
phosphopeptides probed with GST-Nck SH2 and developed with anti-GST antibody. SH2: Src homology 2 domain, Y: tyrosine phosphorylation site. c and d
Overview of the Nck (c) and TSAd (d) Constructs used. WT: wild type, SH3: Src homology 3 domain, PRR: proline rich region, Y: tyrosine phosphorylation site
and F: phenylalanine. e-g Proteins pulled down by GST-Nck SH2 were resolved on SDS-PAGE, and immunoblotted with the indicated antibodies. e GST-Nck
SH2 pull-down from 293T cells transiently transfected with Lck and the indicated HA-tagged TSAd cDNA constructs. Lck immunblot of the GST-Nck SH2
pulldown was negative (data not shown). f As in (e), including TSAd encoding single Y→ F mutations. Relative TSAd binding to GST-Nck SH2 domain was
analysed by ImageJ. Amount of pulled down HA-TSAd WT was set to 1. g GST-Nck SH2 pull-down from pervanadate treated JTAg cells transiently
expressing indicated TSAd Y→ F double mutations. Control GST pull-downs were negative (data not shown). Data shown are representative of at least
three experiments (triple Y→ F TSAd mutant and double mutants) or two experiments (Y→ F single mutants). h Graph shows relative amounts of
HA-TSAd that were pulled down (PD) with GST-Nck SH2 as in (g) measured by ImageJ. Amount of pulled down HA-TSAd WT was set to 1. Mean
values ± SD of three independent experiments (2-tailed paired t-test)
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analyze double Y to F mutants of TSAd for interaction
with Nck SH2 using pull-down experiments in Jurkat
TAg (JTAg) cells transiently expressing HA-tagged
TSAd (Fig. 1g). To ensure maximal tyrosine phosphoryl-
ation of TSAd we chose to treat the TSAd transfected
JTAg cells with the strong tyrosine phosphatase inhibitor
pervanadate (PV) prior to cell lysis and pull down with
Nck SH2. Mutation of both Tyr280 and Tyr305 on TSAd
(Y280, 305F) resulted in disrupted interaction between
TSAd and GST-Nck SH2 (Fig. 1g, lane 4), while TSAd
molecules with either Tyr280 or Tyr305 intact retained
ability to interact with Nck SH2. This pattern of Nck
SH2 interaction could reflect differences in tyrosine
phosphorylation as TSAd pTyr280 is reported twice as fre-
quently in the phophosite.org database as TSAd pTyr305
(Gopalakrishna et al. submitted). However, both TSAd
Tyr280 and Tyr305 are phosphorylated by Lck to a similar
extent in vitro [21], thus the difference in amount of TSAd
mutants pulled down could also reflect differences in
binding affinity, as indicated by SMALI (Fig. 1b). Taken
together, these results confirm the SMALI predicted inter-
action between the Nck SH2 domain and TSAd pTyr280
and pTyr305, with pTyr280 as the preferred binding site.
The proline rich region of TSAd interacts with the SH3
domains of Nck
In addition to one SH2 domain, Nck contains three N-
terminally located SH3 domains (Fig. 1c). PRRs provide
possible interaction sites for SH3 domains, and we have
previously shown that TSAd aa 239–274 harbors binding
sites for Lck and Itk SH3 domains [5, 8]. We thus exam-
ined whether the TSAd PRR could bind to any of the three
Nck SH3 domains. A Scansite search [22] at low strin-
gency identified the Nck SH3.2 domain as a potential
binding partner for TSAd prolines aa 245 (EPSQLLRPKP-
PIPAK) and aa 353 (SVIGQGPPLPHQPPP). Pull-down
experiments in 293T cells (similar to Fig. 1e) expressing
Lck and various TSAd constructs revealed binding of Nck
SH3.1-3 domains to TSAd (Fig. 2a, lane 1). Neither pres-
ence of Lck (Fig. 2a, lane 1 and 3) nor mutation of the
three penultimate tyrosines (Y280,290,305 F) of TSAd
(Fig. 2a, lane 4) affected the interaction with Nck SH3.1-3
while the PRR (Δ239-274) was required for binding to
GST-Nck SH3.1-3 (Fig. 2a, lane 5). Lck has been reported
to interact with Nck-SH3 domains [23]. However, Lck was
not found to interact with Nck-SH3.1-3 in this experiment
(data not shown). These results indicate binding of the
Nck SH3 domains to the PRR of TSAd.
We then studied the TSAd interaction to individual Nck
SH3 domains in more detail. Peptide spot arrays of 20-
mer peptides representing the TSAd PRR showed direct
binding of full length GST-Nck SH3.1-3 domains and all
three GST-Nck SH3 single domains to TSAd peptides
(Fig. 2b). Several classical SH3-ligand motifs are found
within the TSAd PRR peptides that bind to the Nck SH3
domains, including the minimal consensus sequence PxxP,
and the canonical K/RxxPxxP and PxxPxK/R motifs.
Binding of Nck SH3 domains to TSAd prolines were
found to occur primarily within the TSAd PRR aa 239–
274. This observation is in agreement with results from
pull-down data (Fig. 2a), showing abolished Nck SH3 do-
main interaction with TSAd Δ239-274. In comparison, al-
though the C-terminal TSAd sequence aa 359-366 (P359)
displayed some reactivity with the Nck-SH3 domains, this
part of TSAd probably does not represent important Nck
SH3 interaction sites. There are no classical SH3 domain
binding motifs within this region, and pull-down experi-
ments showed no binding of Nck SH3 domains to TSAd
Δ239-274 (Fig. 2a) where aa 359–366 are present.
To confirm interaction of Nck SH3 domains with TSAd,
we performed pull-down assays from 293T cell expressing
TSAd using single GST-Nck SH3 domain constructs.
GST-Nck SH3.1 and SH3.3 both interacted with TSAd
(Fig. 2c). The Nck SH3 interaction with TSAd was con-
firmed in JTAg cells transfected with plasmids encoding
intact HA-tagged TSAd. All three Nck SH3 domains to-
gether (1–3) pulled down similar amounts of TSAd as
Lck-SH3 (Fig. 2d, compare lane 1 and 5), while single Nck
SH3 domains did not pull-down TSAd (Fig. 2d, lane 2–4).
The discrepancy between Nck SH3 binding in 293T and
JTAg cells regarding the single Nck SH3 domains may be
due to other competing Nck-SH3 ligands present in JTAg
cells. The different migration of HA-TSAd that interacted
with Nck SH3.1-3 versus single Nck, Lck or Itk SH3 do-
mains could be due to in-gel interference between the
GST-fusion proteins and TSAd, either due to the molecular
size of the GST protein, or the number of binding sites for
TSAd. Taken together, these results show that Nck may
interact with TSAd also through its SH3 domains, and that
the three SH3 domains interact cooperatively with TSAd.
Both TSAd phosphotyrosines and PRR contribute to
TSAd-Nck interaction
The interaction between TSAd and Nck was further ana-
lyzed in Nck immunoprecipitates (IPs) from 293T cells ex-
pressing Lck together with wild type (WT) or mutated
HA-tagged TSAd molecules and GFP-tagged Nck mole-
cules. TSAd WT co-precipitated with Nck (Fig. 2e, lane 1
and 2). Exon7 encodes most of the PRR and the three C-
terminal TSAd tyrosines (Fig. 1d), which includes the Nck
interaction sites identified in Fig. 1e-g and Fig. 2a-c. TSAd
encoded by cDNA lacking exon7 did not co-
immunoprecipitate with Nck (Fig. 2e, lane 3). Removal of
either the Nck SH2 or SH3 domain interaction sites on
TSAd (Δ239-274 or Y280,290,305F), did not fully abolish
TSAd-Nck interaction (Fig. 2e, lane 4 and 5). Collectively,
these results show that both the phosphotyrosines and the
PRR of TSAd may be engaged in Nck binding.





Fig. 2 The proline rich region (PRR) of TSAd interacts with the Nck SH3 domains. a GST-Nck SH3 pull-downs from 293T cells transiently expressing
the indicated HA-tagged TSAd constructs. Proteins were resolved on SDS-PAGE, and immunoblotted with the indicated antibodies. Control GST
pull-downs were negative (data not shown). Lck immunblot of the GST-Nck SH3 pulldown was negative (data not shown). Results shown are from the
same experiment as shown in Fig. 1e and are representative of at least three experiments. b Peptide spot array spotted with proline containing TSAd
peptides probed with GST-Nck SH3 peptides and developed using anti-GST antibody. Nck SH3 domain interaction sequences on TSAd are boxed
in grey, the TSAd region aa 239–274 is outlined and canonical SH3 ligand motifs and the core PXXP motifs are underlined with black or red lines
respectively. c Pull-down with single GST-Nck SH3 domains and control GST performed as in (a). Results are one representative of three independent
experiments. d Pull-down of GST-Nck SH3 domains in JTAg cells transiently expressing HA-TSAd WT. Positive controls: Itk SH3 and Lck SH3. Negative
control: GST. Blots were immunoblotted with the indicated antibodies. Data is one representative of two experiments. e Nck co-immunoprecipitation
of TSAd expressed in 293T cells. Cells were transiently transfected with Nck-GFP, Lck and the indicated HA-tagged TSAd constructs. Cell lysates and
anti-Nck IP were separated by SDS-PAGE and immunoblotted with indicated antibodies. Data are representative of three independent experiments
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TSAd and Nck co-localize
To further assess whether TSAd and Nck interact in vivo,
we initially performed co-immunoprecipitation experi-
ments from transiently transfected JTAg cells expressing
exogenous TSAd and Nck. TSAd and Nck were found to
co-immunoprecipitate in these cells (Fig. 3a). We then used
confocal microscopy to examine the localization of en-
dogenous Nck and TSAd in CD3/CD28 activated human
CD3+ T cells (Fig. 3b), as well as in JTAg cells transiently
expressing Nck-GFP and TSAd-mCherry (Fig. 3c). This
analysis indicated that TSAd and Nck co-localized in both
human CD3+ T cells and in transfected JTAg cells. TSAd
lacking both the Nck SH2 and SH3 interaction sites (TSAd
ΔExon7), did not co-immunoprecipitate nor co-localize
with Nck (Fig. 3a and c). A faint band was observed for the
TSAd ΔExon7 co-immunoprecipitate with Nck (Fig. 3a).
This band is not specific since it was similar to background
(without the Nck antibody, data not shown).
Co-localization between Nck and intact or mutated
TSAd molecules in JTAg cells was then quantified by
imaging flow cytometry (IFC) (Fig. 3d) using the bright
detail similarity feature of the IDEAS software (Fig. 3e and
f). Compared to TSAd WT, mutation of the Nck SH2
interaction site TSAd Tyr280, did not significantly affect
Nck co-localization (Fig. 3f). However, when expressing
TSAd mutated for all three C-terminal TSAd-tyrosines
(i.e. Y280,290,305F), co-localization with Nck was signifi-
cantly reduced. Again, absence of both the PRR and the
pTyr sites on TSAd (ΔExon7) resulted in disruption of
Nck and TSAd co-localization (Fig. 3f). Taken together,
these results support the notion that TSAd and Nck inter-
act in vivo, and that both Nck SH2 and SH3 domains con-
tribute to this interaction.
TSAd promotes interaction between Nck and Lck
We and others have previously shown that the Src kin-
ase Lck interacts with TSAd [4, 5, 18, 21, 24]. Addition-
ally, Nck has been reported to bind to a proline motif in
the unique domain of Lck [23]. We here examined






Fig. 3 Co-localization of TSAd and Nck in T cells. a Nck co-immunoprecipitation of TSAd expressed in JTAg cells. Immunoblot of Nck-IP and
lysates from JTAg cells transfected with Nck-GFP and HA-TSAd constructs. One representative of three experiments is shown. b Confocal
microscopy images (60× magnification) of one CD3/28 activated human CD3+ T cell, stained with anti-Nck (red), anti-TSAd (green) and
Hoechst 33342 (blue nuclear staining in the merged image). Scale bar = 5 μm. Images are representative of two independent experiments.
c Confocal microscopy images (100× magnification) of transfected, fixed and permeabilized JTAg cells showing Nck-GFP (green), TSAd-
mCherry (red) and merged images with nuclei staining Hoechst 33342 (blue). Images are representative of three independent experiments.
Scale bar = 5 μm. d and e Co-localization of Nck-GFP and the indicated TSAd-mCherry molecules analyzed with the ImageStream cytometer,
gated on double positive GFP and mCherry cells. d Gallery of representative IFC images. e Co-localization analyzed with the “Bright Detail
Similarity” (BDS) algorithm in the IDEAS software. The BDS score is the log transformed Pearson's correlation coefficient of the localized bright
spots with a radius of 3 pixels or less within the masked area in the two input images. Overlay of BDS histograms comparing co-localization of
various TSAd molecules to Nck are shown. Data are representative of four independent experiments. f Percentage of cells that shows high
degree of co-localization (BDS score >2) in (e) for Nck-GFP with each of the TSAd constructs. Graph shows mean ± standard deviation from
four experiments. P-values are indicated (2-tailed paired t-test)
Hem et al. Cell Communication and Signaling  (2015) 13:31 Page 6 of 14
bringing Lck into the vicinity of Nck. We initially used
293T cells as these cells lack expression of T-cell specific
proteins and thus provide a “pure” system to investigate
T cell protein interactions. Cells were transiently trans-
fected with Nck, Lck and/or TSAd cDNA constructs,
and subjected to Nck-IP (Fig. 4a). No interaction of Nck
with Lck was observed (Fig. 4a, lane 2). However, in cells
co-expressing TSAd, Lck co-immunoprecipitated with
Nck (Fig. 4a, lane 3). Moreover, while Nck was tyrosine
phosphorylated in the presence but not in the absence
of Lck, the level of Nck tyrosine phosphorylation was
strongly increased in the presence of TSAd (Fig. 4a,
pTyr-blot, compare lane 2 and 3).
To assess whether TSAd promotes Nck-Lck interaction
also in T cells, we performed Nck co-immunoprecipitation
in lysates from control JTAg cells or JTAg cells where en-
dogenous TSAd expression had been suppressed by
siRNA. Briefly, cells were stimulated with PMA and iono-
mycin over night to increase the amount of endogenous
TSAd, washed, and restimulated with anti-CD3 antibodies.
Nck co-precipitated with TSAd in these cells (Fig. 4b) but
when restimulated with anti-CD3, less interaction of Nck
with TSAd was observed (Fig. 4b and c). Similarly, TSAd
promoted the interaction of Nck with Lck in JTAg cells.
However less Lck was associated with Nck in anti-CD3
stimulated cells (Fig. 4d and e).
Finally we examined the influence of TSAd on Nck-
Lck association in primary T cells, using CD4+ murine
SH2D2A−/+ or SH2D2A−/− blast T cells. The SH2D2A
gene encodes TSAd. In line with the increased Lck co-
immunoprecipitation with Nck in 293T and JTAg cells,
more Nck associated Lck molecules was observed in
SH2D2A−/+ blast T cells compared to the TSAd deficient
SH2D2A −/− blast T cells (Fig. 4f and g). Taken together,
these data suggest that TSAd promotes interaction be-
tween Nck and Lck. In the presence of all three mole-
cules, Nck may become phosphorylated by Lck.
TSAd promotes Nck-SLP-76 interaction
Nck is known to bind to the cytosolic adaptor SLP-76
[13] as well as the guanine nucleotide exchange factor
Vav1 [11]. Since we had established TSAd as an Nck
interaction partner, and since TSAd influenced the inter-
action of Nck with Lck, we explored whether TSAd also
influences interaction of SLP-76 or Vav1 with Nck.
Western blotting of Nck immunoprecipitated from
PMA/ionomycin treated JTAg cells, showed a significant
reduction in Nck and SLP-76 interaction in the absence
of TSAd, both in resting and CD3 restimulated cells
(Fig. 5a and b). In contrast, similar amount of Vav1 was
co-immunoprecipitated with Nck in the presence or ab-
sence of TSAd (Fig. 5a and c). These data suggests that
TSAd not only promotes Nck interaction with Lck, but
also influences Nck’s interaction with some but not all of
its partners.
TSAd promotes F-actin polymerization in T cells
Nck is a known regulator of the actin cytoskeleton [9,
15, 17]. The interaction between TSAd and Nck thus led
us to examine the effect of TSAd on polymerized actin
(F-actin) in JTAg cells. JTAg cells were transfected with
cDNA constructs encoding TSAd WT-mCherry or
TSAd-mCherry lacking both the Nck SH2 and the Nck
SH3 interaction sites (TSAd ΔExon7), and amount of F-
actin was quantified with IFC (Fig. 6). As an internal
reference in each sample, we calculated the relative in-
crease in F-actin in cells that were transfected (mCherry +)
compared to non-transfected cells (mCherry-) (Fig. 6a).
TSAd WT-mCherry transfected cells displayed signifi-
cantly more F-actin than cells expressing either TSAd-
ΔExon7-mCherry or mCherry alone (Fig. 6a and b).
Following anti-CD3 stimulation, an increase in F-actin
content was observed both in the mock transfected and
the TSAd transfected cells (Fig. 6c). However, the rela-
tive increase in F-actin amount in cells expressing TSAd
WT was significantly less pronounced than for cells ex-
pressing mCherry alone (mock) or TSAd-ΔExon7-mCherry
(Fig. 6c and d). Taken together, these data show that TSAd
influence F-actin content in both resting and CD3 stimu-
lated cells, and that this effect is dependent on the Nck and
Lck interaction sites on TSAd.
Discussion
In this work we identified Nck as a novel interaction
partner for TSAd. Through peptide array analysis, pre-
cipitation assays and co-localization studies, we found
that Nck and TSAd interact both through the Nck SH2
domain and the Nck SH3 domains. Moreover, TSAd
promoted interaction of Nck with Lck and SLP-76. Cells
expressing TSAd displayed increased amount of poly-
merized F-actin, while TSAd lacking the Nck and Lck
interaction sites, failed to do so. Interaction of TSAd
with Nck may represent one pathway whereby TSAd
modulates actin polymerization events.
We used scoring matrix-assisted ligand identification
(or SMALI), a web-based program for predicting binding
partners for SH2-containing proteins [20] to identify po-
tential novel interaction partners for TSAd. The SH2 do-
main binding motives were identified by SMALI based
on data from an oriented peptide array library (OPAL)
screening. OPAL allows systematically testing the resi-
dues in the phosphopeptide one by one. The SMALI
analysis covers 76 of the 120 SH2 domains in the gen-
ome. Nck1 SH2 binding to TSAd pTyr280 displayed the
best SMALI score for that particular position in TSAd.
A limitation of using OPAL screening or phage display
techniques to identify SH2 domain binding motifs is that
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amino acids that are prohibitive for SH2 domain inter-
action in a given position may go undetected [25]. Also,
the SMALI analysis only covers 60 % of the existing SH2
domain in the human genome. Thus it is possible that
there are other SH2 domain containing proteins that
also may be predicted to interact with TSAd pTyr280
with a similar probability.
Nck was found to interact with both TSAd pTyr280
and pTyr305, with pTyr280 as the preferred binding site.
We have previously shown that TSAd pTyr280, pTyr290
and pTyr305 provide interactions sites for the Lck SH2
domain [5, 21]. Moreover, we previously showed that
Lck interacts with the same TSAd PRR [18] as Nck (this
paper). It thus appears that Nck and Lck may compete
for the same binding sites on TSAd. However, since
TSAd promoted the association of Nck with Lck, it is
possible that these two molecules may also bind to
TSAd simultaneously. Our current and previous data
suggest that Nck- and Lck-SH2 domains have different
preferences regarding the TSAd phosphotyrosines, with
the pTyr290 [21] or pTyr305as the preferred Lck SH2
binding sites. Of note is that the three C-terminal tyro-
sines of TSAd are highly conserved [5]. This points to a
critical role for these tyrosines in TSAd’s function. Simi-
lar to Lck, Nck has multiple binding sites on TSAd. This
may increase the avidity between Nck and TSAd, and
allow for simultaneous interaction of TSAd with both
Nck and Lck. We did not directly examine whether Nck
and Lck may dock onto the three TSAd pTyr simultan-
eously. However, one intriguing possibility is that one
important function of the C-terminal TSAd tyrosines is
to serve as docking sites for both the Nck and Lck SH2
domains, bringing Lck into the vicinity of Nck and its
binding partners.
In pull-down assays from 293T cells, the Nck SH3 do-
mains 1 and 3 were found to interact, presumably in a
cooperative manner with the PRR of TSAd, while in Jur-
kat cells none of the single SH3 domains were able to
pull down TSAd. This could be due to competition of
individual Nck SH3 domains with other molecules
present in Jurkat cells but not 293T cells, where Lck it-
self is a good candidate. The Nck SH3.2 domain did not
show interaction with TSAd. This is in agreement with







Fig. 4 TSAd promotes Nck and Lck interaction. a Nck co-
immunoprecipitation of TSAd and Lck protein expressed in 293T cells.
293T cells transfected with cDNA encoding Nck-GFP, HA-tagged TSAd
and Lck were subjected to Nck-IP, and immunoblotted with the
indicated antibodies. Data is one representative of three experiments. b
and c Endogenous TSAd co-precipitate with Nck. Immunoblot of Nck-IP
from JTAg cell lysates with TSAd expression (siRNA Control (Ctrl)) or TSAd
knock down (siRNA TSAd (TSAd)). Cells were PMA/Io treated (20 h), and
subsequently stimulated with anti-CD3 (1 min) or left unstimulated.
Lysates were immunoblotted with the indicated antibodies. Results are
one representative of three independent experiments. c Graph shows
relative amounts of TSAd co-precipitated with Nck-IP as shown
in (b) measured by densitometry (ImageJ). Mean values ± SD of
three independent experiments (2-tailed paired t-test). d and e
Co-precipitation of Lck with Nck. Cells were treated as described
in (b). Amount Lck co-precipitated with Nck in unstimulated TSAd
expressing cells (siRNA Control) was set to 1. KD: knock down.
Mean values ± SD of three independent experiments (2-tailed
paired t-test). ns: not statistically significant. f Nck-IP and lysates
from resting CD4+ murine SH2D2A−/+ or SH2D2A−/− blast T cells.
Results shown are one representative out of three independent
experiments. g Graph shows relative amount of Lck co-precipitated
with Nck IP as shown in (f) as measured by ImageJ. Amount of Lck
co-precipitated with Nck in SH2D2A−/+ CD4+ T cells was set to 1.
Mean values ± SD of three experiments. P-values are indicated
(2-tailed paired t-test)
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interaction partners show a clear preference to individ-
ual SH3 domains, and the interaction between Nck li-
gands and the different Nck SH3 domains are often
found to be cooperative [10].
TSAd is expressed only at low levels in naïve T cells,
thus to examine the effect of TSAd we here either used
overexpression of exogenous TSAd or stimulated T cells
with PMA/ionmycin or anti-CD3 to ensure expression
of TSAd. In these cells, Nck and TSAd were found to
constitutively interact without additional stimulation.
Both confocal microscopy and IFC supported the notion
that Nck and TSAd are co-localized in the cytoplasm of
unstimulated Jurkat cells. The intracellular localization of
TSAd has previously been assessed [3, 18, 26]. Although
Fig. 6 TSAd promotes F-actin polymerization in T cells. Actin polymerization in TSAd-mCherry transfected JTAg cells was quantified with imaging
flow cytometer. a Histograms of F-actin intensity (phalloidin) in mCherry+ popoulation versus mCherry- population transfected with mCherry
empty vector (mock, left histogram) and TSAd WT-mCherry (right histogram). One representative of five experiments is shown. b Graph shows relative
amount of F-actin in resting cells shown in (a). Mean ± SD (n = 5) and p-values from 2-tailed paired t-test. c Overlay of histograms of F-actin intensity in
non-stimulated and anti-CD3 (OKT3) stimulated cells for mock and TSAd WT transfected cells. Results shown are one representative of five independent
experiments. d Graph shows relative change in F-actin content in anti-CD3 stimulated cells. Relative change of F-actin content in anti-CD3 stimulated
mock transfected cells was set to 1. Data shown are means ± SD of three independent experiments. P-values estimated by a 2-tailed paired t-test
A B C
Fig. 5 TSAd affects Nck/SLP-76 interaction. Immunoblot of Nck-IP and lysates from JTAg cells with TSAd expression (siRNA Control) or JTAg cells
lacking TSAd (siRNA TSAd), as in Fig. 4b. a Nck-IPs of the same cells shown in Fig. 4b were immunoblotted with the indicated antibodies. Western
blots are from one representative out of four (unstimulated) or three (anti-CD3 stimulated) independent experiments. b Densitometry analysis of
the relative amounts of SLP-76 levels co-immunoprecipitated with anti-Nck antibody from (a) was performed by ImageJ analysis. The amount of
co-immunoprecipitated SLP-76 in unstimulated TSAd expressing control cells was set to 1.0. Data are means ± SD from three independent
experiments. P-values estimated by a 2-tailed paired t-test. c Relative amounts of Vav1 precipitated with anti-Nck antibody as in (b). ns: not
statistically significant
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both we [18] and others [26] previously noted that TSAd
was also located in the nucleus, we observe mainly cyto-
plasmic localization of TSAd in unstimulated cells. We
thus favor the notion that TSAd is primarily a cytosolic
adaptor, linking Lck with some of its substrates, including
also Nck.
In the presence of both TSAd and Lck, Nck phosphor-
ylation was increased. Phosphorylation of Nck has also
been reported previously. However, the physiological sig-
nificance of this phosphorylation event is not clear. Nck
phosphorylation is increased following TCR engagement
in Jurkat cells [27]. c-Abl has been found to phosphoryl-
ate Tyr105 on Nck1, providing a negative feedback loop
on p38 activation upon VEGF-A signaling [28]. Further-
more, Fyn has been reported to phosphorylate Nck. A
model for VEGFR-2 signaling was thus proposed, whereby
the phosphorylated VEGFR-2 recruits Nck via its SH2 do-
main, leading to phosphorylation of Nck and subsequent
recruitment of Fyn and phosphorylation of Nck by Fyn
[29]. We have previously reported that TSAd is recruited to
the activated VEGFR-2 receptor and that in its absence,
VEGF-A stimulation fails to induce actin stress fiber forma-
tion [7]. Moreover, TSAd interacts with Src in endothelial
cells, and is required for activation of Src upon VEGF sig-
naling [6]. Although it needs to be formally demonstrated,
our current study suggests that TSAd may also recruit Nck
to the activated VEGFR-2, providing a possible link be-
tween VEGFR-2 signaling and the actin cytoskeleton.
The role of Nck in T cell activation has been strongly
debated, and reports have been contradictory. Elimin-
ation of Nck with siRNA knock down in Jurkat cells
leads to cells that are hyporesponsive to TCR stimula-
tion [30]. Recruitment of Nck via its SH3.1 domain to a
PRR in the CD3ε, has been proposed to be the earliest
event in TCR triggering [15, 31–34]. Still, the role of
CD3ε-Nck interaction in T cell activation remains con-
troversial [32, 35, 36]. It is possible that Nck recruits a
priming tyrosine kinase to CD3ε, most likely the Src kin-
ase Lck to allow for the phosphorylation of adjacent
CD3ζ subunits [37]. It has previously been reported that
Nck binds to the unique domain of Lck via its SH3 do-
mains, and that phosphorylation of Ser59 disrupts the
interaction [23]. Our current work suggests that TSAd
may link Nck with Lck, providing a scaffold to which
both molecules may bind simultaneously. Alternatively
TSAd may alter Nck or Lck or both thus promoting sub-
sequent interaction of these molecules with each other.
We observed a TSAd independent interaction of Lck with
Nck both in murine T cell blasts lacking TSAd, and in
TSAd suppressed JTAg cells. Since we failed to observe
any interaction between Lck and Nck-SH3.1-3 nor Nck-
SH2 domains in pull-downs in 293T cells, a possible ex-
planation is that a different adapter molecule exist in T
cells that bridges Lck and Nck.
Whether TSAd may be a missing link between CD3ε,
Nck and a kinase, is unclear. It has previously been re-
ported that TSAd is essential for activation of Lck [38].
In contrast we have previously shown that in the ab-
sence of TSAd, CD3ζ is more highly phosphorylated
upon TCR stimulation [21], and vice versa, that when
TSAd is overexpressed, CD3ζ is less phosphorylated
[39]. Our interpretation of this apparent paradox is that
TSAd both serves to activate Lck by interacting with the
Lck SH3 and SH2 domains, and at the same time pro-
vides tyrosines that are substrates for Lck [5]. TSAd may
thus serve as a competitive substrate “sink” allowing
temporary and spatial control of Lck activity, allowing
particular substrates, such as Nck bound to TSAd, to be-
come phosphorylated, while other substrates may be
protected from Lck. With respect to the possible role of
Nck-TSAd-Lck interaction for initiation of TCR signal-
ing, one caveat is also that TSAd is expressed only at
low levels in naïve resting cells. We thus favor a model
where TSAd promoted interaction between Nck and Lck
play a role preferentially in experienced human T cells,
where TSAd expression is already induced. In experi-
enced cells TSAd may contribute to actin dependent
processes, such as migration [8, 40] or stabilization of
the immunological synapse [21].
TSAd also promoted the interaction of Nck with SLP-
76. Nck interacts via its SH2 domain with SLP-76
pTyr113 and pTyr128 upon TCR engagement [11, 13, 17].
Accordingly, we also observed more Nck associated with
SLP-76 in our restimulated JTAg cells. In comparison
Nck-Vav1 dimers are proline dependent and are consti-
tutively formed [11, 12] which fits with our observation
that the interaction between Nck and Vav1 remained
unaffected by TSAd.
How TSAd may affect SLP-76 interaction with Nck re-
mains to be studied. An intriguing observation was that
upon CD3 stimulation, less TSAd and more SLP-76 was
associated with Nck. Our observation that Lck is re-
cruited to Nck in the presence of TSAd, indicates that
the Lck and TSAd together primes Nck for interaction
with SLP-76. Additionally, the kinase Itk is also a bind-
ing partner for both SLP-76 [12] and TSAd [8, 21, 41].
One possibility is that TSAd, Lck, Itk, Nck and SLP-76
participate in a multimolecular complex, where each of
the molecules may interact with several of the other
molecules in a cooperative manner.
Conclusions
We report a novel association between TSAd and Nck.
In the presence of TSAd, association of Nck with Lck as
well as SLP-76 is increased. This may allow recruitment
of Lck into the vicinity of Nck binding partners, and
thus provide a mechanism whereby TSAd influence the
actin cytoskeleton.
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Methods
Plasmids and constructs
TSAd cDNA was cloned into the pEF-HA expression
vector, and constructs encoding full-length TSAd [39],
TSAd Δ239-274, TSAd ΔExon 7 (aa 239–334) [18], sin-
gle, double and triple TSAd tyrosine (Y) to phenylalan-
ine (F) mutants [5] were cloned as previously described.
Point mutations in TSAd cDNA were generated by
QuickChange™ Site-Directed Mutagenesis (Stratagene).
mCherry tagged TSAd constructs were cloned into the
pcDNA3 vector. Nck1-GFP and GST-Nck1 constructs
were provided by L. Buday [42]. The GST-Lck SH3 and
GST-Itk SH3 constructs were generated as described
[4, 8, 18]. All constructs were verified by sequencing.
Antibodies
The following monoclonal antibodies were used: anti-
Lck (3A5), anti-SLP-76 (F7), and anti-GST (B12) (Santa
Cruz Biotechnology,Inc.), anti-HA (HA.11, Bio Site),
anti-Nck (108; BD Transduction Laboratories™), anti-
human CD3ε (OKT3; American Type Culture Collec-
tion), anti-phosphotyrosine (4G10; Upstate Biotechnol-
ogy), and unconjugated and DyLight 488 conjugated
anti-TSAd (anti-SH2D2A) (3C7, Origene). The following
polyclonal antibodies were used: anti-Nck (Millipore),
anti-Vav (C-14; Santa Cruz Biotechnology,Inc.) and anti-
TSAd (1715 T, provided by V. Shapiro). Horse radish
peroxidase (HRP)-conjugated goat anti-mouse IgG, goat
anti-mouse IgG light chain specific and goat anti-rabbit
IgG (all from Jackson ImmunoResearch Laboratories),
and goat-anti rabbit IgG Alexa Fluor® 647 conjugate
(Molecular Probes) were used as secondary antibodies.
Expression and purification of recombinant GST-fusion
proteins
GST-fusion proteins of Nck SH2, Nck SH3, Lck SH3
and Itk SH3 domains were produced in E.coli BL21-
Codon Plus® (Stratagene) in M9 minimal salt media at
15 °C, and purified on Glutathione 4B SepharoseTM
beads (GE Healthcare), according to the manufacturer’s
instructions. Protein concentration and purity were ana-
lyzed by SDS-PAGE and Commassie Brilliant Blue
Staining.
Cell cultures and transfections
Human embryonic kidney (293T) cells (American Type
Culture collection) and Jurkat SV40 T antigen (JTAg)
cells [43] were cultured in complete RPMI (cRPMI)
medium [RPMI 1640 supplemented with 5 % (293T
cells) or 10 % FBS (JTAg cells), 1 mM sodium pyruvate,
10 mM Hepes, 1 % MEM non-essential amino acids,
100 units/ml penicillin, 100 μg/ml streptomycin (all
from GIBCOBRL®, Life Technologies™) and 0.5 μM 2-
mercaptoetanol (Sigma). Transfections of 1.5 · 107 JTAg
cells in RPMI 1640 with 0.5-10 μg of plasmid DNA were
performed using a BTX electroporator (Genetronix) at
240 V and 25 ms. Transient transfectants were cultured
for 16–24 h. 293T cells (2.2 · 106) were plated in 5 ml
complete media on 10 cm cell culture plates, and
allowed to adhere for 24 h. The transfection solution
containing 0.04-6 μg DNA and 42.4 μg/ml polyethylenei-
mine (PolyScience) in PBS was added drop-wise to the
293T cells. Transfected cells were further propagated for
16–24 h.
siRNA-mediated knock down of TSAd expression
JTAg cells (1.5 · 107) were transiently transfected with
1 μM solution of TSAd siRNA [7] to inhibit TSAd ex-
pression or control siRNA (24 h in total), as previously
described [18]. After transfection, cells were stimulated
with 50 ng/ml phorbol 12-myristate 13-acetate (PMA)
and 500 ng/ml Ionomycin (Io) (both from Sigma) for
20 h to induce TSAd expression.
Mice and propagation of murine CD4+ T blast cells
Mice used in this study were bred under conventional con-
ditions, and approved by The National Animal Research
Authority, via their local representative at the University of
Oslo. The mice were regularly screened for common path-
ogens and housed in compliance with guidelines set by the
Experimental Animal Board under the Ministry of Agricul-
ture of Norway. TSAd deficient (SH2D2A−/− or RIPB-KO)
C57BL/6 mice were kindly provided by Professor J. A.
Bluestone [41] and the SH2D2A−/− mice were back-
crossed >10 generations into C57BL/6 mice and main-
tained on a C57BL/6 background as described [7].
Murine splenocytes and lymph node cells were ob-
tained by crushing the organs through a cell strainer
(70 μm nylon, BD Biosciences). CD4+ T cells were puri-
fied from splenocytes or lymph node by negative selec-
tion (Dynal® Mouse CD4 Negative Isolation Kit
(114.15), Life Technologies). The recovered population
was more than 93 % CD4+ T cells, as analyzed by flow
cytometry (FACS Calibur, BD Biosciences). For propa-
gation of blast cells from primary murine CD4+ T cells,
30U mouse IL-2/ml and Dynabeads® Mouse T-Activator
CD3/CD28(Life Technologies) (following the manufac-
turer’s protocol) was added to the cRPMI medium.
Isolation and activation of human CD3+ T cells
Peripheral blood mononuclear cells (PBMCs) from
healthy donors were isolated from buffy coats using
Lymphoprep™ as previously described [44]. CD4+ T cells
were isolated by negative selection (Dynabeads® Un-
touched Human T cells (113.44D), Life Technologies).
The recovered population was more than 95 % CD3+ T
cells, as analyzed by flow cytometry (FACS Calibur, BD
Biosciences). Cells were activated with Dynabeads®
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Human T-Activator CD3/CD28 (one bead per cell), fol-
lowing the manufacturer’s protocol (Life Technologies)
in cRPMI medium for 48 h.
Cell stimulation and lysis
Prior to use in experiments, the anti-CD3/CD28 beads
were removed from long term activated murine CD4+ T
cells and cells were rested for 24–48 h before harvesting.
For short time activation of JTAg cells, the cells were
washed with PBS, resuspended to 5 · 107 cells/ml and
stimulated with 5 μg/ml anti-CD3 (OKT3) antibody for
the indicated time points. In some experiments pervana-
date treatment for 5 min (0,01 % H2O2, 100 μM
Na3VO4) was used. Stimulation was terminated by add-
ing ice cold PBS and centrifugation. Cells were lysed in
lysis buffer containing; 1 % Nonidet-P40, 50 mM n-
octyl-β-D-glucoside, 25 mM Tris (pH 7.5), 100 mM
NaCl, 20 mM NaF, 1 mM Na3VO4 and 1× protease in-
hibitor cocktail (Roche) for 30 min on ice. For co-
immunoprecipitation, reduced amounts of detergents
were used; 0.25 % Nonidet-P40 and 12,5 mM n-octyl-β-
D-glucoside. LDS lysis were used for immunoprecipita-
tion in murine CD4+ T cells (final concentration) 0.1 %
LDS, 1 % Triton X-100, 0.1 M LiCl, 1 mM PMSF, 5 mM
EDTA, 50 mM Hepes, 1 mM Na3VO4 and 1× protease
inhibitor cocktail.
Immunoprecipitation and pull-down assays
For immunoprecipitation (IP), lysates from 293T and
JTAg cells were pre-cleared three times for 30–45 min
with Dynabeads Protein G (Life Technologies), and incu-
bated with the relevant antibodies conjugated to Dyna-
beads Protein G (Life Technologies) for 1 h at 4 °C. For
pull-down assays, cell lysates from 2.2 · 106 -1.5 · 107 cells
were pre-cleared three times for 30 min with a 2:1 mix-
ture of GST/Glutathione SepharoseTM 4B beads (GE
Healthcare), and added to aliquots of Glutathione
SepharoseTM 4 Fast Flow (GE Healthcare) coupled GST-
fusion proteins. The mixture was rotated for 1 h at 4 °C.
Beads from IP or pull-down were washed three times in
1× lysis buffer, and precipitated proteins were separated
by SDS-PAGE and detected by immunoblotting. Quanti-
fication was performed on ECL autoradiography films
using ImageJ software [45].
SDS-PAGE and Western blot
Proteins were denatured in SDS loading buffer, separated
by SDS-PAGE, and transferred to a PVDF membrane
(Bio-Rad Laboratories) using a Hoefer Semi-Phor Semi-
Dry Transfer Unit (Amersham Biosciences), or a Trans-
Blot® Turbo™ Transfer System (BioRad). Blots were
blocked in PBS-T (pH 7.4, 0.1 % Tween) with 3 % BSA
(Biotest) or 3 % skimmed milk (Sigma), and subse-
quently incubated with the indicated antibodies in the
appropriate blocking buffer. Signals were detected by
horseradish peroxidase (HRP)-labeled secondary anti-
bodies and Super Signal® west Pico Stable Peroxide Solu-
tion (Pierce), and developed on Amersham Hyperfilm™
ECL (GE Healthcare).
SMALI predictions of SH2 interactions
The web based scoring matrix-assisted ligand identifica-
tion (SMALI) algorithm [19, 20], was used to predict
SH2 domains interacting with phosphotyrosine peptides
of TSAd [NP_003966.2]. A domain scan was carried out.
A relative SMALI score greater than 1.0 indicated a
strong potential binding.
Peptide spot array analysis
Peptide arrays were synthesized on nitrocellulose mem-
branes using a MultiPep automated peptide synthesizer
(INTAVIS Bioanalytical Instruments AG) as described
[46]. Membranes were spotted with relevant TSAd pep-
tides and probed with GST-tagged Nck SH2 and SH3 fu-
sion proteins (50–150 μg/ml), followed by anti-GST
antibody and anti-mouse HRP secondary antibody. Signals
were detected by chemiluminescent detection by Super
Signal® West Pico stable peroxide solution (Pierce).
Confocal microscopy
JTAg transfectants were harvested 16–24 h post trans-
fection for confocal microscopy analysis. For human
CD3+ T cells activated with anti-CD3/CD28 Dynabeads,
beads were removed. 1 · 106 cells were washed in PBS,
adhered to polylysine microscope slides (VWR) for
10 min, fixed with 4 % paraformaldehyde (Fluka Che-
mika) for 10 min, and rinsed twice with washing buffer
(PBS, 2 % FCS). Subsequently, the cells were perme-
abilized with 0.1-0.3 % Triton X-100 in PBS for 5 min,
stained with 2 μg/ml Hoechst 33342 (Molecular Probes)
for 20 min, rinsed twice with washing buffer. Human
CD3+ T cells were further stained with 5 μg/ml anti-
Nck (Millipore) and anti-TSAd DyLight 488 (2.5 μg/ml)
for 1 h, rinced three times and stained with goat-anti
rabbit IgG Alexa Fluor® 647 (10 μg/ml) for 1 h, rinced
three times with washing buffer. Both Jurkat cells and
human CD3+ T cells were rinced once with dH2O be-
fore mounted with SlowFade® Gold (Life Technologies)
and sealed with nail polish. Confocal images were ac-
quired on an Olympus Fluoview FV1000 BX61WI up-
right microscope equipped with a PlanApo 100× NA
1.40 oil objective.
Imaging flow cytometry
JTAg cells co-transfected with Nck-GFP and TSAd-
mCherry constructs were harvested 16–24 h post trans-
fection. Cells were incubated with 2 μg/ml Hoechst
33342 (Molecular Probes) for 20 min, washed in PBS,
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fixed with 4 % paraformaldehyde (Fluka Chemika) for
10 min, and rinsed twice with PBS. Data of 1-3 · 104 cells
per sample were acquired on a 12-channel ISX Imaging
Flow Cytometer with 40× objective (Amnis Corpor-
ation). Samples were acquired with a bright-field (BF)
area lower limit of 50 μm2 to eliminate debris. Single
stained controls were collected with no illumination and
with excitation lasers switched on. The data was ana-
lyzed using IDEAS 4.0 software (Amnis). The IDEAS
compensation wizard was used to create a compensation
matrix for single stained image files. The matrix was
used to correct for spectral overlap in raw sample files.
F-actin polymerization analysis
JTAg cells transfected with empty vector mCherry (mock),
TSAd-mCherry or mutated TSAd-mCherry constructs
were harvested 20 h post transfection. The cells were in-
cubated with 2 μg/ml Höechst 33342 in RPMI for
20 min for nuclear staining prior to harvesting. 1 · 106
cells were washed once in PBS and subsequently resus-
pended in 100 ul PBS and stimulated with anti-CD3
(OKT3, 10 μg/ml) for 30 s at 37 °C or PBS as unstimu-
lated control. Stimulation of cells was terminated by
addition of 100 μl fixation/permeabilization/staining solu-
tion consisting of 8 % paraformaldehyde, 0.25 mg/ml L-
α-lysophosphatidylcholin) and 1,25U Alexa Fluor® 647
phalloidin (Life Technologies). Cells were washed twice
with 2 % FBS in PBS (pH 7.4), and resuspended in 50 μl
PBS for analysis of phalloidin intensity on a 12-channel IS
Imaging Flow Cytometer with 40× objective (Amnis
Coporation). The data was analysed using IDEAS 6.1 soft-
ware (Amnis) and FlowJo.
Statistical analysis
Quantitative data are shown as mean ± standard deviation.
Statistical significance was defined as P- values < 0.05 and
was estimated by a 2-tailed paired Student’s t test.
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